BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$85.60+0.56 (+0.66%)
Close on Nov 13, 2026Market cap $21.50BP/E –Yield –
BioNTech enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioNTech's enterprise value was $13.47B on Nov 11, 2026, against $13.43B a year earlier. Over the last 5 years it ranged from $6.61B to $62.97B, with a median of $14.37B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $13.47B | +18.3% |
| 2025 | Dec 31, 2025 | $11.39B | -24.2% |
| 2024 | Dec 31, 2024 | $15.02B | +45.5% |
| 2023 | Dec 29, 2023 | $10.32B | -70.5% |
| 2022 | Dec 30, 2022 | $34.94B | -44.5% |
| 2021 | Dec 31, 2021 | $62.97B | +277.1% |
| 2020 | Dec 31, 2020 | $16.70B | +178.3% |
| 2019 | Dec 31, 2019 | $6.00B | – |
See a number that looks wrong?